HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nima Rezaei Selected Research

Dichlororibofuranosylbenzimidazole (DRB)

8/2016HLA-DRB and HLA-DQB Allele and Haplotype Frequencies in Iranian Patients with Recurrent Aphthous Stomatitis.
8/2013HLA-DRB, -DQA, and DQB alleles and haplotypes in Iranian patients with diabetes mellitus type I.
3/2009HLA class II (DRB, DQA1 and DQB1) allele and haplotype frequencies in the patients with pemphigus vulgaris.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Nima Rezaei Research Topics

Disease

70Neoplasms (Cancer)
09/2022 - 07/2007
66COVID-19
11/2022 - 01/2020
52Infections
05/2022 - 04/2006
34Inflammation (Inflammations)
08/2022 - 01/2010
27Primary Immunodeficiency Diseases
01/2022 - 12/2006
26Common Variable Immunodeficiency
01/2020 - 01/2004
17Autoimmune Diseases (Autoimmune Disease)
12/2021 - 04/2008
15Asthma (Bronchial Asthma)
01/2021 - 09/2008
14Multiple Sclerosis
09/2022 - 11/2009
14Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2021 - 01/2014
11Breast Neoplasms (Breast Cancer)
07/2022 - 12/2019
11Reinfection
01/2022 - 07/2005
10Hypersensitivity (Allergy)
03/2022 - 01/2009
10Bruton type agammaglobulinemia
01/2021 - 01/2004
9Neoplasm Metastasis (Metastasis)
04/2022 - 12/2004
9Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 12/2012
9Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2022 - 03/2010
8Heart Failure
04/2020 - 07/2010
8Agammaglobulinemia (Hypogammaglobulinemia)
01/2020 - 03/2004
8Aphthous Stomatitis (Aphthous Ulcer)
10/2018 - 01/2014
8Febrile Seizures (Febrile Seizure)
06/2017 - 01/2014
8Hyper-IgM Immunodeficiency Syndrome (Hyper-IgM Syndrome)
01/2014 - 01/2004
7Crohn Disease (Crohn's Disease)
04/2022 - 06/2014
7Virus Diseases (Viral Diseases)
02/2022 - 06/2011
7Autosomal Recessive 3 Severe Congenital Neutropenia
01/2022 - 09/2007
7Neutropenia
01/2021 - 12/2003
7Cystic Fibrosis (Mucoviscidosis)
03/2020 - 03/2010
7Juvenile Arthritis (Juvenile Idiopathic Arthritis)
10/2018 - 08/2016
7Allergic Rhinitis
01/2017 - 12/2010
6Cytokine Release Syndrome
08/2022 - 09/2020
6Parkinson Disease (Parkinson's Disease)
06/2022 - 01/2017
6Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
01/2022 - 09/2008
6Tuberculosis (Tuberculoses)
01/2022 - 06/2006
6Carcinogenesis
12/2021 - 10/2016
6Chronic Granulomatous Disease
10/2020 - 08/2006
6Autoimmune Hepatitis
01/2019 - 11/2012
6Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2018 - 06/2014
6IgA Deficiency
01/2013 - 06/2008
5Seizures (Absence Seizure)
10/2022 - 01/2014
5Glioblastoma (Glioblastoma Multiforme)
09/2022 - 04/2020
5Epilepsy (Aura)
03/2022 - 03/2010
5Communicable Diseases (Infectious Diseases)
03/2022 - 09/2011
5Eosinophilia
01/2022 - 01/2009
5Alzheimer Disease (Alzheimer's Disease)
01/2022 - 01/2018
5Atherosclerosis
01/2022 - 09/2010
5Ataxia Telangiectasia (Louis Bar Syndrome)
01/2022 - 01/2004
5Intervertebral Disc Degeneration
02/2021 - 10/2018
5Bacterial Infections (Bacterial Infection)
01/2020 - 01/2006
5Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2019 - 11/2016

Drug/Important Bio-Agent (IBA)

81CytokinesIBA
09/2022 - 06/2006
41VaccinesIBA
11/2022 - 02/2005
36Immunoglobulins (Immunoglobulin)IBA
01/2022 - 12/2003
29Biomarkers (Surrogate Marker)IBA
11/2022 - 10/2012
21Toll-Like Receptors (Toll-Like Receptor)IBA
06/2022 - 01/2008
20Proteins (Proteins, Gene)FDA Link
06/2022 - 09/2011
19Pharmaceutical PreparationsIBA
03/2022 - 01/2009
19Immunoglobulin G (IgG)IBA
01/2022 - 01/2004
18Interleukin-6 (Interleukin 6)IBA
03/2022 - 01/2009
15Interleukin-10 (Interleukin 10)IBA
09/2022 - 11/2008
15Immunoglobulin A (IgA)IBA
01/2022 - 03/2007
15Monoclonal AntibodiesIBA
01/2022 - 09/2008
14AntigensIBA
01/2022 - 06/2008
14Immunoglobulin M (IgM)IBA
01/2022 - 03/2007
13Intravenous Immunoglobulins (IVIG)FDA Link
07/2022 - 03/2004
13MicroRNAs (MicroRNA)IBA
06/2022 - 10/2013
13Interleukin-4 (Interleukin 4)IBA
01/2022 - 01/2010
12InterferonsIBA
07/2022 - 10/2016
12Immune Checkpoint InhibitorsIBA
01/2022 - 01/2020
12Antiviral Agents (Antivirals)IBA
01/2022 - 12/2011
11AntibodiesIBA
07/2022 - 03/2010
11Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2022 - 01/2008
11InterleukinsIBA
01/2022 - 01/2009
11Interleukin-2 (IL2)IBA
01/2022 - 06/2008
10LigandsIBA
01/2022 - 02/2014
10Polysaccharides (Glycans)IBA
01/2022 - 07/2007
10Immunoglobulin E (IgE)IBA
01/2022 - 01/2006
9Transforming Growth Factor beta (TGF-beta)IBA
01/2022 - 11/2008
8Brain-Derived Neurotrophic Factor (BDNF)IBA
09/2022 - 04/2017
8Adrenal Cortex Hormones (Corticosteroids)IBA
07/2022 - 10/2010
8DNA (Deoxyribonucleic Acid)IBA
06/2022 - 12/2006
8Immunoglobulin IsotypesIBA
01/2014 - 07/2005
7Interleukin-17 (Interleukin 17)IBA
03/2022 - 11/2016
7Interleukin-12 (IL 12)IBA
01/2020 - 11/2008
6Interferon-gamma (Interferon, gamma)IBA
09/2022 - 01/2017
6Anti-Bacterial Agents (Antibiotics)IBA
01/2022 - 03/2009
6Interleukin-1 (Interleukin 1)IBA
01/2022 - 06/2014
6Agammaglobulinaemia Tyrosine KinaseIBA
01/2021 - 12/2004
6CD40 Ligand (CD40L)IBA
01/2019 - 03/2007
5SolutionsIBA
11/2022 - 06/2013
5Messenger RNA (mRNA)IBA
06/2022 - 10/2016
5AutoantibodiesIBA
01/2022 - 05/2015
5Insulin (Novolin)FDA Link
01/2021 - 05/2012
5NucleotidesIBA
01/2021 - 01/2015
5EnzymesIBA
01/2021 - 01/2015
5AlbuminsIBA
01/2021 - 06/2011

Therapy/Procedure

70Therapeutics
09/2022 - 02/2006
34Immunotherapy
08/2022 - 03/2012
12Drug Therapy (Chemotherapy)
06/2022 - 07/2010
7Radiotherapy
02/2022 - 12/2004
5Hematopoietic Stem Cell Transplantation
01/2022 - 02/2013